ATE353213T1 - Agglomerate mit hohem ibuprofen-gehalt und deren herstellungsverfahren - Google Patents

Agglomerate mit hohem ibuprofen-gehalt und deren herstellungsverfahren

Info

Publication number
ATE353213T1
ATE353213T1 AT92918509T AT92918509T ATE353213T1 AT E353213 T1 ATE353213 T1 AT E353213T1 AT 92918509 T AT92918509 T AT 92918509T AT 92918509 T AT92918509 T AT 92918509T AT E353213 T1 ATE353213 T1 AT E353213T1
Authority
AT
Austria
Prior art keywords
agglomerates
weight
isobutylphenyl
pct
propionic acid
Prior art date
Application number
AT92918509T
Other languages
English (en)
Inventor
Graham John Atkin
Peter Drew
John Leslie Turner
Original Assignee
Reckitt Benckiser Healthcare
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Reckitt Benckiser Healthcare filed Critical Reckitt Benckiser Healthcare
Application granted granted Critical
Publication of ATE353213T1 publication Critical patent/ATE353213T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1688—Processes resulting in pure drug agglomerate optionally containing up to 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Rheumatology (AREA)
  • Neurosurgery (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT92918509T 1991-09-06 1992-08-25 Agglomerate mit hohem ibuprofen-gehalt und deren herstellungsverfahren ATE353213T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB919119052A GB9119052D0 (en) 1991-09-06 1991-09-06 Pharmaceutical compositions

Publications (1)

Publication Number Publication Date
ATE353213T1 true ATE353213T1 (de) 2007-02-15

Family

ID=10700981

Family Applications (1)

Application Number Title Priority Date Filing Date
AT92918509T ATE353213T1 (de) 1991-09-06 1992-08-25 Agglomerate mit hohem ibuprofen-gehalt und deren herstellungsverfahren

Country Status (16)

Country Link
US (1) US5512302A (de)
EP (1) EP0602112B1 (de)
JP (1) JP3444597B2 (de)
KR (1) KR100253046B1 (de)
AT (1) ATE353213T1 (de)
AU (1) AU655673B2 (de)
CA (1) CA2116956C (de)
CZ (1) CZ282271B6 (de)
DE (1) DE69233678T2 (de)
FI (1) FI107878B (de)
GB (1) GB9119052D0 (de)
IL (1) IL103005A (de)
IN (1) IN174169B (de)
RU (1) RU2123841C1 (de)
WO (1) WO1993004676A1 (de)
ZA (1) ZA926709B (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI101039B (fi) * 1992-10-09 1998-04-15 Eeva Kristoffersson Menetelmä lääkepellettien valmistamiseksi
HUP0104606A3 (en) * 1998-12-18 2003-01-28 Basf Ag A pharmaceutical mixture comprising a profen
US6726929B1 (en) 1998-12-18 2004-04-27 Basf Aktiengesellschaft Pharmaceutical mixture comprising a profen
US6251945B1 (en) * 1999-01-14 2001-06-26 Knoll Aktiengesellschaft Pharmaceutical mixture comprising a combination of a profen and other active compounds
DE10003757A1 (de) 2000-01-28 2001-08-02 Knoll Ag Ibuprofen-Wirkstoffzubereitung
US20040173147A1 (en) * 2001-06-07 2004-09-09 Figueroa Iddys D. Application of a bioactive agent to a delivery substrate
US6962715B2 (en) * 2001-10-24 2005-11-08 Hewlett-Packard Development Company, L.P. Method and dosage form for dispensing a bioactive substance
US20040173146A1 (en) * 2001-06-07 2004-09-09 Figueroa Iddys D. Application of a bioactive agent to a delivery substrate
DE10153934A1 (de) * 2001-11-06 2003-05-22 Basf Ag Verfahren zur Kristallisation von Profenen
US20050203482A1 (en) * 2004-03-15 2005-09-15 Chinea Vanessa I. Pharmaceutical dispensing apparatus and method
US20050202051A1 (en) * 2004-03-15 2005-09-15 Chinea Vanessa I. Pharmaceutical vehicle
JP2008266270A (ja) * 2007-04-25 2008-11-06 Kowa Co イブプロフェン、トラネキサム酸及び糖アルコールを含有する固形製剤

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3883098T2 (de) * 1987-07-08 1993-12-02 American Home Prod Sprühgetrocknete Ibuprofen-Zusammensetzungen.
US5240712A (en) * 1987-07-17 1993-08-31 The Boots Company Plc Therapeutic agents
US4837031A (en) * 1987-09-17 1989-06-06 Mallinckrodt, Inc. Compositions containing ibuprofen
US4911921A (en) * 1989-02-02 1990-03-27 Mallinckrodt, Inc. High ibuprofen content granulations
US5266723A (en) * 1989-05-16 1993-11-30 Medice, Ltd., Chem.-Pharm. Fabrik Putter Gmbh & Co. Kg Process for the preparation of optically active 2-aryl-alkanoic acids, especially 2-aryl-propionic acids
US5087454A (en) * 1990-07-30 1992-02-11 American Home Products Corporation Ibuprofen tablet
US5260337A (en) * 1992-07-29 1993-11-09 Merck & Co., Inc. Ibuprofen-muscle relaxant combinations
US5332834A (en) * 1992-12-02 1994-07-26 Hoechst Celanese Corporation Racemization of an enantomerically enriched α-aryl carboxylic acid

Also Published As

Publication number Publication date
JPH06510532A (ja) 1994-11-24
CZ49994A3 (en) 1994-07-13
RU2123841C1 (ru) 1998-12-27
FI941046A0 (fi) 1994-03-04
JP3444597B2 (ja) 2003-09-08
FI941046A (fi) 1994-03-04
IN174169B (de) 1994-10-01
EP0602112B1 (de) 2007-02-07
IL103005A (en) 1996-01-19
DE69233678T2 (de) 2008-01-24
DE69233678D1 (de) 2007-03-22
WO1993004676A1 (en) 1993-03-18
CA2116956C (en) 2002-07-16
US5512302A (en) 1996-04-30
AU655673B2 (en) 1995-01-05
AU2487092A (en) 1993-04-05
CA2116956A1 (en) 1993-03-18
FI107878B (fi) 2001-10-31
IL103005A0 (en) 1993-01-31
ZA926709B (en) 1993-04-28
CZ282271B6 (cs) 1997-06-11
KR100253046B1 (ko) 2000-05-01
EP0602112A1 (de) 1994-06-22
GB9119052D0 (en) 1991-10-23

Similar Documents

Publication Publication Date Title
DE69916922T2 (de) Ibuprofenhaltige Arzneizubereitung
ATE353213T1 (de) Agglomerate mit hohem ibuprofen-gehalt und deren herstellungsverfahren
DE102005026755A1 (de) Herstellung von festen Lösungen schwerlöslicher Wirkstoffe durch Kurzzeitüberhitzung und schnelle Trocknung
KR960016204B1 (ko) 비스테로이드성 소염제를 함유하는 약제학적 제제
KR960021061A (ko) 경구 투여용 약제학적 조성물
DE69935609T2 (de) Formulierungen enthaltend cefuroxim-axetil
AU670048B2 (en) Immediate-effect ibuprofen-containing medicament and its use
Pandit et al. In vitro-in vivo evaluation of fast-dissolving tablets containing solid dispersion of pioglitazone hydrochloride
EP0559645A1 (de) Zusammensetzung für feste pharmazeutische zubereitungen, die aktives vitamin-d3 enthalten und verfahren für ihre herstellung
DD300404A5 (de) Pharmazeutische zubereitung
JPS59181224A (ja) 安定なインタ−フエロン製剤の製法
JP2010095464A (ja) 皮膚外用剤およびその製造方法
RU94019417A (ru) Способ получения фармацевтической композиции, фармацевтическая композиция, фармацевтический препарат, способы получения фармацевтического препарата
JPH0813736B2 (ja) 単斜結晶構造を有する熱―、光―、及び湿気―感受性活性成分を含む錠剤又は糖剤組成物の調製方法
DE69910188T2 (de) Arzneiformen enthaltend carvedilol
JP2891744B2 (ja) パントテン酸カルシウム組成物およびその製造方法
Rojas Excipient design by co-processing for direct compression applications
DE60024132T2 (de) Einen histamin h 2 antagonisten enthaltende brausezusammensetzung
WO2014094956A1 (de) Magnesiumhydroxidcarbonat als träger in pharmazeutischen zubereitungen mit verbesserter wirkstofffreisetzung
JP2000007556A (ja) チュアブル錠
DE10341264A1 (de) Schmelzformulierte, multipartikuläre orale Darreichungsform
JPH10298074A (ja) ビタミン類含有組成物
KR101476096B1 (ko) 용해도가 향상된 쎄레콕시브의 약제학적 조성물
JP2720079B2 (ja) 酸性非ステロイド性抗炎症薬含有薬剤
JPH0959161A (ja) 疲労改善用組成物

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0602112

Country of ref document: EP

REN Ceased due to non-payment of the annual fee